Difteri diagnose

Den nuværende definition af difteri bruges af centrene for sygdomsbekæmpelse og forebyggelse (CDC) er baseret på både laboratorium og kliniske kriterier.

Kriterier for laboratoriediagnose

Isolering af '' Corynebacterium diphtheriae'' fra klinisk prøvemateriale, eller
Histopatologisk diagnosticering af difteri

Kliniske kriterier

Øvre luftveje sygdom med ondt i halsen
høj kvalitetsgrad feber, og
En vedhængende pseudomembrane tonsil(s), svælget og næse.

Kategorisering af tilfælde

Sandsynlige: klinisk kompatibel tilfælde, der ikke laboratorium-bekræftet og epidemiologisk ikke er knyttet til et laboratorium-bekræftet tilfælde
Bekræftet: en klinisk kompatibel sag, er enten laboratorium-bekræftet eller epidemiologisk forbundet med et laboratorium-bekræftet tilfælde

Empiriske behandling bør generelt startes en patient i hvem mistanke om difteri er høj.

Yderligere lµsning

Denne artikel er licenseret under Creative Commons Attribution-ShareAlike License. Det bruger materiale fra Wikipedia artikel om "difteri" alle materiale tilpasset anvendes fra Wikipedia er tilgængelig under betingelserne i Creative Commons Attribution-ShareAlike License . Wikipedia ®, selv er et registreret varemærke tilhørende Wikimedia Foundation, Inc.

Recent Diphtheria News

Some public health advocates disagree with Indian government's decision to roll out pentavalent vaccines, IPS reports"Ignoring widespread concern over the safety, efficacy and cost of pentavalent vaccines" -- which provide protection against diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenza type ...

Nigeria's first-ever national Vaccine Summit addresses child mortality burdenNigeria's top government officials, civil society leaders and leaders of private industry resolved today to join forces to expand vaccine access nationwide, a major step in the fight to reduce child m...

Large childhood immunization campaign begins in Haiti, with support from U.S., other international partnersHaiti, the U.S. and other international partners on Monday launched "a nationwide vaccination campaign in the Caribbean country that seeks to curb or prevent infectious diseases, health officials said...

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpointsPfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and esta...

Breakthrough discovery about Rhizobium radiobacterA new discovery involving two Simon Fraser University scientists could lead to a little known and benign bacterium becoming a vital new tool in the development of a vaccine against human immunodeficie...